GMP Excipient & Raw Material Manufacturing and Sourcing Demands on the Rise
Material suppliers will face more scrutiny and will need a deeper understanding of manufacturing partners and sites, regulatory reputation and material quality, says Gearoid O'Rourke, Marketing Director at Aceto
The Covid-19 pandemic showed the fragility of global biopharma supply chains, forcing companies to reconsider and rethink their current strategy more carefully. Pharma companies will continue to strongly shift their focus towards security of supply and the resilience of their supply chain.
Thus, material suppliers will face more scrutiny and will need a deeper understanding and knowledge of their manufacturing partners and sites, their regulatory reputation, and material quality. At Aceto, we have long believed in following a strong sales, inventory, and operations (SIOP) process to mitigate any risks and ensure on-time delivery to our customers. Aceto’s primary advantage remains our strong procurement teams that are strategically located in key regions, including those across Asia and Europe. These procurement professionals constantly keep in touch with our sales teams and provide real-time feedback on any potential delays.This further ensures that our customers are informed on-time and can plan their buying patterns accordingly.
Fulfilling Biologic Material Supply: An Approach to Meet Growing Excipient & Raw Materials Needs
Before COVID pandemia, the biologic medicines market was estimated to experience continued yearly growth over 10% and the rapid response of large molecule manufacturers to manufacture vaccines and other biologic drugs for COVID-19 is an another obvious cause for recent spikes in demand. Prior to the pandemic, Aceto had already recognized the growing demands in the biopharmaceutical industry for high quality critical GMP excipients and raw materials. As part of our growth strategy in the biopharmaceutical market we expanded our manufacturing footprint by acquiring five companies in the last 12 months, increasing our R&D and GMP manufacturing capabilities in North America, Europe and Asia. This robust GMP manufacturing presence in strategic geographical regions globally provides Aceto with the ability to respond to customers customization demands as well as providing specific manufacturing and R&D expertise to complement our existing distribution model. The five companies acquired were:
- A&C- a GMP manufacturer of excipients and raw materials for the biopharmaceutical market.
- Cascade Chemistry- a manufacturer of active pharmaceutical ingredients (APIs), regulatory starting materials and advanced intermediates.
- Finar- a GMP manufacturer, supplier, and distributor of pharmaceutical excipients.
- Islechem- a chemical manufacturing, also offers contract research and development (R&D), analytical services, and technical support services.
- Syntor Fine chemicals- a fine chemical manufacturer offering process development and R&D services.
Bringing Together Diverse Solutions to Secure Biopharma Supply Chains
Aceto’s manufacturing plants can provide customized functional excipients with full supporting regulatory and quality dossiers. In addition, we also have access to over 3,000 chemical compounds through our procurement centers of excellence globally. All our supply partners are approved and audited by our global quality auditing team. Our Quality Assurance and Quality Control teams are formed by highly skilled and qualified experts with many years of experience in the pharmaceutical & biopharmaceutical industry and work with our partners to ensure compliance with all pharmaceutical and biopharmaceutical standards and requirements is constantly respected. Aceto will only purchase products from specifically approved plants that meet our strict guidelines for quality. We regularly visit our partners to evaluate them not only on the basis of ability to deliver satisfactory products on a timely and cost-efficient basis, but also on quality system, facilities and equipment system, materials system, production system, packaging and labeling system, and laboratory control system.
Aceto offers customers a strong manufacturing base, to complement years of sourcing experience, and to bring customers more complete solutions. Our facilities, based in the US, Canada, UK, and India operate to both GMP and non-GMP quality standards depending on the application, and are backed by a globally aligned R&D organization. All facilities work closely with customers to develop advanced intermediates, APIs and excipients, as well as niche specialty chemicals.
Together, Aceto now manages over 5,000 international shipments of chemicals per year and boasts a market leading on-time in full rate. Key to this success has been Aceto’s regulatory team, which has over 70 years of quality and regulatory experience, with expertise working with agencies like FDA, European Medicines Agency (EMA), Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), Environmental Protection Agency (EPA), Toxic Substances Control Act (TSCA), and Occupational Safety and Health Administration, OSHA, standards. Knowing how to move highly regulated goods around the world is just as important as the ability to manufacturer them. To keep up with the growing biopharma space, suppliers must both diversify their global manufacturing capabilities and heavily invest in logistics. Doing so, will help bring more incredible biologic medicines to patients around the world, wherever needed.
Related News
-
News On track at Pharmapack 2024 - The Track Sponsor interview: Gerresheimer
January 2024 brings both a new year and Europe’s leading packaging and drug delivery event. Gathering the world’s experts in pharmaceutical packaging together in Paris, France, Pharmapack 2024 offers exciting opportunities to learn and coll... -
News The Patient-Centric Synergy of Pharmaceutical CDMO and CRO Collaborations
Pharmaceutical collaborations are nothing new to the industry. Increasingly complex drug development programs, calls for supply chain resiliency, and the involvement of all key stakeholders throughout a drug’s development lifecycle are pushing co... -
Sponsored Content Discover Our Organic Mineral Salts as APIs
Discover the range of organic mineral salts that serve as Active Pharmaceutical Ingredients available from Dr. Paul Lohmann®. -
Sponsored Content CPHI Podcast Series: Ursatec – celebrating 30 years of pioneering preservative free
In the latest episode of the CPHI Podcast Series, Digital Editor Lucy Chard spoke with Dominik Rocchi of Ursatec. -
News Seqens Group Expands CDMO Offerings to Include CRDO
Meet with Seqens team members at CPHi, April 25-27, 2023 to learn how we have extended services to rapidly and sustainably advance drug development. VISIT CPHI Booth 441 -
News CDMO - Health is a Joint Project: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Emanuele Agnese, Business Development Manager and Pietro Allegrini, R&D Director at Indena, present the ways in which a reliable manufacturing partner in the pursuit of better health outcomes for patients and pharm... -
News Streamlined Development for Efficient Production of Bispecific Molecules: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Séverine Fagète, VP, Cell Line Development Services at Selexis (Geneva, Switzerland), and Brandon Brino (Durham, USA), Process Development Scientist and Group Leader at KBI Biopharma, present an overv... -
News MDR – How to collect post-market clinical follow-up data (PMCF): Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Philipp Annecke, Junior Key Account Manager and Heinrich Martens, VP Regulatory Affairs of Fresenius Kabi (Bad Homburg, Germany) present guidances from the Medical Devices Regulation on clinical data evaluatio...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance